Absolute contraindications to the use of dapsone are prior hypersensitivity to dapsone or its derivatives including agranulocytosis and hypersensitivity syndrome. Deaths from agranulocytosis, aplastic anemia, and other blood dyscrasias have been reported with dapsone administration.

Relative contraindications to the use of dapsone include allergy to sulfonamide antimicrobials, significant cardiopulmonary disease, significant liver or renal function impairment, or pre-existing peripheral neuropathy.

For the treatment of women who are pregnant, dapsone is a category C drug. Therefore, it should be used with caution only if the benefits outweigh the risks.

According to the American Academy of Pediatrics, dapsone is listed as a "maternal medication usually compatible with breastfeeding."